Mihael Potocki
Overview
Explore the profile of Mihael Potocki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meune C, Balmelli C, Elianevogler , Twerenbold R, Reiter M, Reichlin T, et al.
Int J Cardiol
. 2013 Dec;
171(2):e13.
PMID: 24374204
No abstract available.
2.
Meune C, Balmelli C, Vogler E, Twerenbold R, Reiter M, Reichlin T, et al.
Int J Cardiol
. 2013 Jul;
168(4):3752-7.
PMID: 23849971
Background: The introduction of high-sensitivity cardiac troponin (hs-cTn) assays allows the assessment of clinical decision values below the 99th percentile. Methods: Final diagnosis and one-year mortality were adjudicated in a...
3.
Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, et al.
Arch Intern Med
. 2012 Aug;
172(16):1211-8.
PMID: 22892889
Background: High-sensitivity cardiac troponin (hs-cTn) assays seem to improve the early diagnosis of acute myocardial infarction (AMI), but it is unknown how to best use them in clinical practice. Our...
4.
Eckstein J, Potocki M, Murray K, Breidthardt T, Ziller R, Mosimann T, et al.
Heart
. 2012 Aug;
98(20):1518-22.
PMID: 22865868
Objectives: Due to different release mechanisms, mid-regional pro-atrial natriuretic peptide (MR proANP) may be superior to N-terminal pro-B-type natriuretic peptide (NT proBNP) in the diagnosis of acute heart failure (AHF)...
5.
Potocki M, Ziller R, Mueller C
Curr Heart Fail Rep
. 2012 Jun;
9(3):244-51.
PMID: 22733501
Circulating biomarkers have become increasingly important in diagnosing and risk-stratifying patients with heart failure (HF). While the natriuretic peptides have received much focus in the past decade, there is increasing...
6.
Wu A, Tabas J, Stein J, Potocki M, Mueller C, McCord J, et al.
Biomarkers
. 2012 May;
17(6):490-7.
PMID: 22616939
Serum mid-regional pro-atrial natriuretic peptide (MR-proANP) and pro-adrenomedullin (MR-proADM) are novel biomarkers for acute heart failure (AHF). Like other AFH biomarkers, the performance of these tests are affected by the...
7.
Breidthardt T, Vanpoucke G, Potocki M, Mosimann T, Ziller R, Thomas G, et al.
Clin Sci (Lond)
. 2012 May;
123(9):557-66.
PMID: 22587491
The risk stratification in patients presenting with acute dyspnoea remains a challenge. We therefore conducted a prospective, observational cohort study enrolling 292 patients presenting to the emergency department with acute...
8.
Potocki M, Reichlin T, Thalmann S, Zellweger C, Twerenbold R, Reiter M, et al.
Heart
. 2012 Feb;
98(7):558-65.
PMID: 22337952
Objective: The early diagnosis of acute myocardial infarction (AMI) can be particularly challenging in patients with known coronary artery disease (CAD) due to pre-existing ECG changes and chronic increases in...
9.
Maisel A, Neath S, Landsberg J, Mueller C, Nowak R, Peacock W, et al.
Eur J Heart Fail
. 2012 Feb;
14(3):278-86.
PMID: 22302662
Aims: Biomarkers have proven their ability in the evaluation of cardiopulmonary diseases. We investigated the utility of concentrations of the biomarker procalcitonin (PCT) alone and with clinical variables for the...
10.
Breidthardt T, Socrates T, Drexler B, Noveanu M, Heinisch C, Arenja N, et al.
Crit Care
. 2012 Jan;
16(1):R2.
PMID: 22226205
Introduction: The accurate prediction of acute kidney injury (AKI) in patients with acute heart failure (AHF) is an unmet clinical need. Neutrophil gelatinase-associated lipocalin (NGAL) is a novel sensitive and...